Mastering Single Cell Proteomics: Daily Excellence with μPAC Neo Plus Trap-and-Elute Workflow

Importance of the topic

Single-cell proteomics (SCP) addresses the critical need to measure proteome composition and heterogeneity at the level of individual cells. Improvements in chromatography, sample handling and mass spectrometry sensitivity enable discovery of cellular subpopulations, signaling states and biomarker candidates that are obscured in bulk measurements. Practical applications include basic cell biology, immunology, pharmacology, and biopharmaceutical QA/QC where low-input samples and high day-to-day robustness are essential.

Study aims and overview

This presentation documents optimization of a routine, high-sensitivity SCP workflow built around the µPAC Neo Plus micro‑pillar array column and trap‑and‑elute sample handling. The goals were to maximize identifications from ultralow peptide amounts (true single cells and pg-level digests), to maintain practical instrument productivity for daily operations, and to demonstrate performance trade-offs between direct injection and trap-and-elute approaches under realistic laboratory conditions.

Methodology and workflow

• Workflow optimization targeted minimal sample loss at every step: single-cell isolation, one‑pot digestion, low‑volume transfer, trapping, and low‑flow nanoLC–MS.
• Two principal loading strategies compared: direct injection of concentrated small-volume samples versus trap‑and‑elute (backward‑flush and forward‑flush) for dilute or larger-volume single‑cell extracts.
• Variable-flow approaches (forming part or all of the gradient at high flow, then switching to low‑flow elution) were evaluated to balance sensitivity and instrument productivity.
• Data acquisition used both Orbitrap Exploris and Orbitrap Astral platforms with DIA windows optimized for long MS2 accumulation times to increase depth at low input; data processing employed match-between-runs and Spectronaut 19 for identification and quantitation.

Used Instrumentation

• µPAC Neo Plus micro‑pillar array LC columns (50 cm format): ordered pillar geometry (1.25 µm interpillar distance), core–shell porous layer, C18 functionalization; column design optimized for low‑flow nanoLC and low sample loads.
• Thermo Scientific Vanquish Neo UHPLC: precise low‑volume aspiration and vial‑bottom detection enabling full aspiration of µL‑scale single‑cell digests and rapid sample uptake.
• Thermo Scientific OptiSpray ion source and cartridges: automated emitter positioning, reproducible nano‑ESI performance and plug‑and‑play convenience.
• Mass spectrometers: Orbitrap Exploris 240 and Orbitrap Astral (higher throughput/depth); typical settings included narrow DIA windows, extended MS2 injection times, and high MS2 resolution for low‑input samples.
• Software: Spectronaut 19 for DIA processing and match‑between‑runs; complementary Thermo software tools used for method and system control.

Main results and discussion

• µPAC Neo Plus columns deliver notably sharper peaks and higher sensitivity at sub‑200 nL/min flows compared with conventional packed columns due to ordered pillar arrays and reduced dispersion; this improves peptide detectability from ultralow inputs.
• Lowering flow into the low‑nL/low‑hundreds nL‑per‑minute regime substantially increases ion signal (qualitatively several‑fold versus µL‑scale flows), though exact gains depend on system geometry and ionization efficiency.
• Trap‑and‑elute trade-offs: switching from direct injection to backward‑flush trap‑and‑elute resulted in an average proteome depth loss around 10% (at concentrated small‑volume injections). Forward‑flush trap workflows produced larger losses (20–40%) attributable mainly to increased peak width rather than selective loss of hydrophilic peptides.
• Using Vanquish Neo with optimized aspirate and trap volumes reduces effective sample loading times (to ~2–2.5 min for concentrated small‑volume samples) and maintains higher instrument productivity; variable‑flow gradient strategies can recover 55–83% instrument productivity depending on how much of the gradient is formed at high flow before switching to low‑flow elution.
• Performance benchmarks: optimized µPAC Neo Plus trap‑and‑elute workflows showed comparable identification numbers to leading packed‑column setups at ultralow loads (examples: multi‑thousand protein groups per well‑controlled single‑cell experiments, and 4k–6k protein groups in state‑of‑the‑art configurations reported for low inputs).
• Practical single‑cell experiments confirmed correlation between cell size and identified proteome depth; selecting narrow size bins improves reproducibility.

Benefits and practical applications

• High sensitivity at routine throughput: µPAC Neo Plus enables deep proteome coverage from single cells or pg‑level digests while supporting daily laboratory operation and multi‑dozen samples per day when optimized.
• Reduced sample loss: ordered pillar geometry, minimized dead volumes, and careful sample handling reduce losses critical for true single‑cell work.
• Flexible productivity/sensitivity trade-offs: variable flow and trap strategies allow labs to tune methods for either maximum depth or higher sample throughput without hardware changes.
• Operational robustness: standardized fittings, on‑source mounting, and automated OptiSpray features yield reproducible performance across users and columns, simplifying routine SCP deployment.
• Applicability: single‑cell biology, immunopeptidomics, targeted peptide mapping, and early‑detection biomarker studies where input material is limiting.

Future trends and potential applications

• Continued gains in MS sensitivity (e.g., Astral‑class detectors) and software-driven identifications (data‑independent acquisition and advanced match‑between‑runs) will push routine single‑cell coverage higher and more quantitative.
• Integration of microfabricated columns with automated sample preparation and high‑throughput microfluidics will further reduce losses and increase experiment scale.
• Standardized low‑volume sample handling (vial bottom detection, automated aspiration) and robust ESI cartridges will accelerate adoption of SCP in regulated environments and multi‑user facilities.
• Method harmonization (column geometries, gradient strategies, trap configurations) and community benchmarks will clarify best practices for different biological questions and sample types.

Conclusion

Optimizing single‑cell proteomics for routine use requires coordinated improvements in chromatography, sample handling and mass spectrometry. The µPAC Neo Plus pillar‑array column combined with Vanquish Neo sample handling and modern Orbitrap platforms offers a practical path to sensitive, robust, and relatively high‑throughput SCP. Trap‑and‑elute workflows enable handling of dilute or variable‑volume single‑cell digests with modest losses compared with direct injection, and variable‑flow gradient strategies recover instrument productivity without sacrificing sensitivity. Together, these advances make daily single‑cell proteomics increasingly feasible for research and applied laboratories.

References

1. He B., Tait N., Regnier F. Fabrication of nanocolumns for liquid chromatography. Anal. Chem. 1998, 70, 3790–3797. (Early pillar‑array/CEC performance characterization.)
2. Gzil P., Vervoort N., Baron G. V., Desmet G. Advantages of perfectly ordered 2‑D porous pillar arrays over packed bed columns for LC separations: a theoretical analysis. Anal. Chem. 2003, 75, 6244–6250. (CFD simulations quantifying separation efficiency improvements.)
3. Thermo Fisher Scientific application materials and system notes: µPAC Neo Plus columns, Vanquish Neo UHPLC, OptiSpray source, Orbitrap Exploris and Astral platforms; Spectronaut 19 processing (as reported in the seminar dataset).